title: Treatment of infectious keratitis with riboflavin and ultraviolet-A irradiation.
abstract: We report 4 eyes with infectious keratitis treated with riboflavin/ultraviolet-A irradiation (corneal collagen crosslinking [CXL]) in addition to medical treatment. In 2 eyes with bilateral keratitis, the fellow eye was treated with medical treatment alone. The other 2 eyes had refractory keratitis. The results suggest that CXL may be more worthwhile in cases refractory to conventional medical treatment.
  
  
  BACKGROUND
  No author has a financial or proprietary interest in any material or method mentioned.
authors.affiliation: From the Centre for Eye Research Australia, University of Melbourne, and the Royal Victorian Eye & Ear Hospital, Melbourne, Australia.
authors.forename: Elsie
authors.initials: E
authors.lastname: Chan
authors.affiliation: From the Centre for Eye Research Australia, University of Melbourne, and the Royal Victorian Eye & Ear Hospital, Melbourne, Australia.
authors.forename: Grant R
authors.initials: GR
authors.lastname: Snibson
authors.affiliation: From the Centre for Eye Research Australia, University of Melbourne, and the Royal Victorian Eye & Ear Hospital, Melbourne, Australia. Electronic address: laurence.sullivan@gmail.com.
authors.forename: Laurence
authors.initials: L
authors.lastname: Sullivan
mesh_terms: D015823:Acanthamoeba Keratitis / Q000175:diagnosis / Q000188:drug therapy* / Q000469:parasitology; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003094:Collagen / Q000378:metabolism; D003131:Combined Modality Therapy; D063171:Corneal Pachymetry; D003319:Corneal Stroma / Q000187:drug effects / Q000378:metabolism; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D003432:Cross-Linking Reagents / Q000627:therapeutic use; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D015822:Eye Infections, Parasitic / Q000175:diagnosis / Q000188:drug therapy* / Q000469:parasitology; D005260:Female; D005469:Fluorometholone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D010865:Pilot Projects; D011008:Pneumococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D012256:Riboflavin / Q000627:therapeutic use*; D014466:Ultraviolet Rays; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D003432:Cross-Linking Reagents; D017319:Photosensitizing Agents; D014640:Vancomycin; D003094:Collagen; D005469:Fluorometholone; D012256:Riboflavin